A Board of 8 AI agents analyzes every S&P 500 company like a team of senior analysts — in seconds, not days.
No credit card required · 10 free analyses, no sign-up needed
Suggested by the Board
Just browsing? Explore the live screener →
NYSE · Industrials · Large Cap
Board Conviction
2/100
Not a weak signal — a split board. Computed from the agents' closing labels, not written by the model.
Margin of Safety
−21.8%
IV $229.74–$285.89 vs $293.68
A no-growth-credit frame — the price-discipline check, not the verdict.
Devil's Advocate Agent
“Elevated debt-to-equity (1.78) and a negative margin of safety (−21.8%) leave the company vulnerable to cyclical downturns in a tepid 1.5% GDP growth environment.”
Agent Pipeline
8 / 8 agents completed
Features
The S&P 500 ranked by EV/EBIT — on the median operating profit of up to 15 fiscal years, where the free screeners use the last twelve months. On NVDA that window is 19x less flattering.
Macro, Quant, and an NLP agent (10-K RAG) build the bull case. A Risk Manager stress-tests it. The Portfolio Manager arbitrates and issues a BUY / HOLD / SELL verdict — every step on record.
Add tickers to your watchlist. The board re-checks them every night — a changed verdict, an earnings surprise, fresh news — and flags what moved in your notifications.
Each BUY/SELL is stamped with an entry price the moment it's issued. Performance is recalculated every market close — no cherry-picking, no rewriting.
October 4, 2026 · 15 min read
Seventy-four cents on the dollar, and no equity left
HCA Healthcare's shares have fallen 22% since March. Over the last three fiscal years its revenue rose 26% and its net income 20%, and at Friday's close the market pays 74 cents for each dollar the accounts support with no growth at all. It is also a company with no book equity left — it has spent it buying back its own shares — and the market's worry is about who pays its bills next year. It is the eleventh cheapest of the 100 companies that clear our two gates; the machine's pick is A. O. Smith, for the third Sunday running. This piece also withdraws a cushion our own Sunday table printed for it.
September 27, 2026 · 14 min read
Priced for no growth, and still growing
Accenture's shares have lost 56% since February 2025. Over the same stretch its revenue set a record every year and its latest quarter grew 5.6%, with earnings per share up 9%. At Friday's close the market pays 95 cents for each dollar the accounts support with no growth at all — everything above the price is the credit our frame gives the franchise record, and whether that record survives AI is the whole disagreement. It is the eighth cheapest of the 100 companies that clear our two gates, expensive on its own fifteen-year past and cheap on its last twelve months; the machine's pick is A. O. Smith, again. This piece also corrects a label in our own Sunday table.
September 20, 2026 · 12 min read
A charge at the end of the window
Cognizant's operating profit rose 17% in its last fiscal year and its shares sit 30% below their January high. It is the second cheapest of the 104 companies that clear our two gates — and our own screen blocks it, on a net-income line that a single non-cash tax charge turned from up 14% to down 3%. Last week a one-off charge at the start of the window overstated a company's growth; this week one at the end erases it. This piece is about publishing against our own filter, and saying so.
A Real Board Transcript
Most tools give you a verdict. This one shows you the argument behind it — and tells you how much of the board actually backed it.
14 Aug 2026 · $158.61
Not a weak signal — a split one. Every agent took a side, and they split three-three. The score is computed from their closing labels, not written by the model.
Quantitative Agent
Step 2 — Earnings Power Value (EPV) EPV = ($34.42B × 16.7x) ÷ 4.305B = $133.51 Step 3 — FCF Perpetuity Value FCF-IV = $31.19B ÷ 0.0599 ÷ 4.305B = $120.95 Step 6 — Margin of Safety MoS = ($120.95 − $158.61) ÷ $158.61 = -23.7% Classification: OVERVALUED
Every figure is computed in Python and handed to the model to audit — never generated by it.
Devil's Advocate — Risk Critique
The stock is currently priced for perfection at a 23.7x P/E multiple despite a clear, multi-year trend of free cash flow contraction and a lower ROE than its peers, leaving no margin of safety for a cyclical downturn.
Portfolio Manager — Final Decision
While technicals and recent earnings show positive momentum, the stock's overvalued status (-23.7% margin of safety) and multi-year decline in free cash flow dictate a cautious stance.
One real run, quoted verbatim — not a performance claim and not a recommendation. Run XOM yourself and you will get that day's numbers, not these.
How It Works
AAPL, MSFT, NVDA, GOOG — any S&P 500 company.
8 agents analyze fundamentals, sector dynamics, macro risks, technicals, and 10-K filings — 6 in parallel.
Get a structured report with charts and a timestamped recommendation, exportable as PDF.
Join investors using Sperio.ai to uncover value before the market does.
Start Analyzing →10 free analyses · No credit card required